Longevity Health Holdings Inc.
Longevity Health Holdings Inc. (XAGE) Revenue
Annual & quarterly revenue history · segment & region breakdown
XAGE · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsLongevity Health Holdings Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 3701.44% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2021 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | +$0.00B | +3701.44% |
| 2024-12-31 | $0.00B | +$0.00B | — |
| 2023-12-31 | $0.00B | +$0.00B | — |
| 2022-12-31 | $0.00B | +$0.00B | — |
| 2021-12-31 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Longevity Health Holdings Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Longevity Health Holdings Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Longevity Health Holdings Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
XAGE revenue · 4 questionsXAGE's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 3701.44% year-over-year from $0.00B in FY2025.
▸ Source: FMP · Longevity Health Holdings Inc. SEC filings · GAAP · Longevity Health Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026